Join to view full profile
12902 Usf Magnolia Dr# GuTampa, FL 33612
Phone+1 813-745-8343
Fax+1 813-745-8494
Dr. Fishman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of South Florida Morsani College of Medicine/Moffitt Cancer Center/Tampa General HospitalFellowship, Hematology and Medical Oncology, 1997 - 2000
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1993 - 1996
University of Maryland School of MedicineClass of 1993
Certifications & Licensure
FL State Medical License 1997 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification PowerChart (Clinical), Cerner Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification FairWarning® Patient Privacy Monitoring, FairWarning Technologies, LLC, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification PowerChart (CQM), Cerner Corporation, 2014, 2016-2017
Clinical Trials
Publications & Presentations
PubMed
- Current Clinical Utility of Gene Expression Panels in Primary Cutaneous Melanoma.Taylor L Garza, Jae Hwan Choi, Michelle McGee, Edmond Box, Timothy Nywening
Cancers. 2026-06-03 - Pembrolizumab plus high-dose IL-2 in advanced clear cell renal cell carcinoma: six-year survival outcomes and molecular signatures from a phase 2 trial.Jeffrey S Johnson, Justin W Miller, Firas Hatoum, Michael J Schell, Xiaoqing Yu
Nature Communications. 2026-05-25 - 2 citationsApproaches to Treating High Risk and Advanced Renal Cell Carcinoma (RCC): Key Trial Data That Impacts Treatment Decisions in the Clinic.Jonathan Chatzkel, Mayer Fishman, Brian Ramnaraign, Padraic O'Malley, Guru P Sonpavde
Research and Reports in Urology. 2024-01-01
Press Mentions
Tampa General Hospital Improves Access to Cancer Care and Treatment in the Riverview AreaSeptember 17th, 2021
Combination Axitinib + Pembrolizumab Active Against Renal Cell CarcinomaFebruary 16th, 2018
Impact of Sequencing Targeted Therapies with High-Dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients with Metastatic Renal Cell Carcinoma from an on-Going Observational IL-2 Clinical Trial: PROCLAIM SMFebruary 1st, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
